Instead of shotgun marketing and advertis ing, Hagimo works directly with payers and providers to reach out to eligible patients directly, based on medical histories already contained in our data platform. With more than half a trillion data points on millions of Americans, assembling groups of patients who meet the inclusion and exclusion crite ria of a mass tort takes minutes instead of months.
Read More
Hagimo LLC is uniquely poised to help implement and offer the nation's first complete value-based healthcare transition solutions. Working with a select group of channel partners, Hagimo LLC can trend facility, practice, and provider data, identify problems and opportunities as dened under the relevant portions of the ACA, and develop new procedures and supply chain strategies designed to maximize facility compliance with the federally-mandated transition to value-based care.
120M+ patients (medical codes, providers, payers, compounds, labs), 5M+
providers, 95% US facilities, International Data, Media Markets, Ethnic
Breakouts, U.S. Census Data, Lifestyle
Data, and more.
With more than 20 years of experience in developing standards-conformal platforms (we received our first 'third party' HIPAA conformal certification in 2006), Hagimo LLC remains current on HIPAA certification training, and all applicable standards com pliance. Combined with real-world experi ence in developing enterprise scale data platforms designed for management of and controlled access to sensitive medical data, Hagimo LLC is uniquely qualified to save you time and money by working directly with your technology team, assisting them in every facet of standards-conformal devel opment, from design through development and implementation.
Read More
With data covering more than half of the insured population of the United States, Hagimo LLC is able to monitor hundreds of medical compounds and devices in real time. Changes in incidence rates, co-mor bidities, hospital visits, emergency room returns, adverse reactions, and other data can be refreshed constantly and reviewed by our automated systems. Trends that indicate significant variances from the general population are detected and poten tial problems identified months or even years before they become apparent to the medical community. Payers can adjust coverage and policies, pharma entities can review and revise formulations and designs, potential legal ramifications can be extrap olated and defined, and more
With more than 13 million crosswalks from nearly every payer, Hagimo's transaction analytics provide an unprecedented level of detail, speed, and automation in scanning all of your 835/837 transaction data. Catch mistakes and isolate fraud attempts before they affect your bottom line!
Hagimo, LLC is committed to bringing disruptive technology to several verticals in the near term (2022-2023). We're located in downtown Nashville, TN, with data clusters here and international data housed in Basel, Switzerland. We're small, flexible, nimble, fast, and we're building next-gen technolo gy solutions right now. Please reach out to us for more information.